Integrative computational analysis of Marburg virus protein mutations: structural and functional implications of

Emre Aktaş1, Sema Öztürk1, Bilgesu Tarhan1

  • 1Faculty of Art and Science, Molecular Biology and Genetics, Yıldız Technical University, Istanbul, Türkiye.

Insights

Marburg virus mutations in its glycoprotein (GP) can alter its structure and function, potentially aiding immune evasion. While some plant compounds show limited antiviral promise, known inhibitors are more effective.

Area of Science:

  • Virology and Molecular Biology
  • Computational Biochemistry
  • Drug Discovery

Background:

  • Marburg virus (MARV) is a deadly filovirus causing severe hemorrhagic fever outbreaks.
  • Understanding MARV Glycoprotein (GP) mutations is crucial for developing antiviral strategies.
  • MARV GP mediates viral entry by interacting with host cell receptors like AXL, TYRO3, and MER.

Purpose of the Study:

  • To investigate the structural and functional impact of MARV GP mutations.
  • To evaluate the antiviral potential of selected plant-derived compounds against MARV using computational methods.

Main Methods:

  • Comparative sequence analysis to identify recurrent MARV GP mutations.
  • Molecular dynamics simulations to assess mutation-induced structural changes and receptor interactions.
  • Computational screening (docking) of plant compounds (Aesculetin, Carvacrol, Cinnamaldehyde, Eugenol, Geranial) against MARV GP and host receptors.

Main Results:

  • Mutations P278L and D364Y in MARV GP were predicted to cause structural damage, reduce receptor binding (TYRO3, MER), and potentially facilitate immune evasion.
  • Aesculetin showed minimal binding affinity to MARV GP, while other natural compounds had weaker interactions.
  • Known synthetic inhibitors (IN-1, IN-2, IN-3) exhibited significantly stronger binding than the tested plant compounds.

Conclusions:

  • MARV GP possesses structural plasticity, with specific mutations impacting its stability and host interactions.
  • Plant-derived compounds like Aesculetin have limited potential as MARV antivirals compared to established inhibitors.
  • Further research into MARV GP structure-function relationships is warranted for effective antiviral development.